Patent: 9,527,845
Summary for Patent: 9,527,845
| Title: | Derivatives and methods of treating hepatitis B infections |
| Abstract: | Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject. |
| Inventor(s): | Hartman; George D. (Lansdale, PA), Kuduk; Scott (Harleysville, PA) |
| Assignee: | NOVIRA THERAPEUTICS, INC. (Doylestown, PA) |
| Application Number: | 14/984,293 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,527,845
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | RECOMBIVAX, RECOMBIVAX HB | hepatitis b vaccine (recombinant) | Injection | 101066 | July 23, 1986 | 9,527,845 | 2035-12-30 |
| Merck Sharp & Dohme Llc | RECOMBIVAX, RECOMBIVAX HB | hepatitis b vaccine (recombinant) | Injection | 101066 | February 26, 1996 | 9,527,845 | 2035-12-30 |
| Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | August 28, 1989 | 9,527,845 | 2035-12-30 |
| Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | June 4, 2004 | 9,527,845 | 2035-12-30 | |
| Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | June 13, 2008 | 9,527,845 | 2035-12-30 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
